Navigation Links
Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Third Quarter Results on Friday, February 8, 2008
Date:1/31/2008

BETHESDA, Md., Jan. 31 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX) a leading independent American provider of Western healthcare products and services in the People's Republic of China, announced that it intends to release its financial results for the third quarter ended December 31, 2007, on Friday, February 8, 2008.

Chindex's management will also host a conference call on Friday, February 8, 2008 at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time; 11:00 p.m. China time) to discuss its financial results.

To participate, international callers dial 201-689-8566, domestic callers dial 877-407-0709 approximately 10 minutes before the conference call is scheduled to begin.

The telephone replay will be available two hours after the call at (international) 201-612-7415 and (domestic) 877-660-6853, pass code 273077; and continue to be available through February 22, 2008.

This call is also being webcast by Vcall and can be accessed at Chindex's website http://www.chindex.com/news/financial.cfm or at http://www.InvestorCalendar.com . The event will be archived and available for replay through May 9, 2008.

About Chindex International, Inc.

Chindex is an American healthcare company that provides healthcare services and supplies medical capital equipment, instrumentation and products to the Chinese marketplace, including Hong Kong. It provides healthcare services through the operations of its United Family Hospitals and Clinics, a network of private primary care hospitals and affiliated ambulatory clinics in China. The Company's hospital network currently operates in the Beijing and Shanghai metropolitan areas. The Company sells medical products manufactured by various major multinational companies, including Siemens AG, which is the Company's exclusive distribution partner for the sale and servicing of color doppler ultrasound systems. It also arranges financing packages for the supply of medical products to hospitals in China utilizing the export loan and loan guarantee programs of both the U.S. Export-Import Bank and the German KfW Development Bank. With twenty-five years of experience, more than 1,000 employees, and operations in China, Hong Kong, the United States and Germany, the Company's strategy is to expand its cross-cultural reach by providing leading edge healthcare technologies, quality products and services to Greater China's professional communities. Further company information may be found at the Company's websites, http://www.chindex.com and http://www.unitedfamilyhospitals.com .

Statements made in this press release relating to plans, strategies, objectives, economic performance and trends and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, the terms, conditions, covenants, requirements and limitations set forth in the documents relating to the above financing, risks and uncertainties relating to the development to completion of the proposed two new and/or expanded hospital facilities on budget if at all and factors set forth under the heading "Risk Factors" in our annual report on Form 10-K for the year ended March 31, 2007, updates and additions to those "Risk Factors" in our interim reports on Form 10-Q and in other documents filed by us with the Securities and Exchange Commission from time to time. Forward- looking statements may be identified by terms such as "may", "will", "should", "could", "expects", "plans", "intends", "anticipates", "believes", "estimates", "predicts", "forecasts", "potential", or "continue" or similar terms or the negative of these terms. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. We have no obligation to update these forward-looking statements.

For more information, please contact:

Lawrence Pemble or Judy Zakreski

Chindex International, Inc.

Tel: +1-301-215-7777


'/>"/>
SOURCE Chindex International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Chindex International, Inc. to Present at 2008 UBS Global Healthcare Services Conference
2. Chindexs United Family Hospitals and Clinics and NBC Enter into Healthcare Services Agreement
3. JPMorgans Principal Investment Management Group to Invest in Chindex International, Inc.
4. QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Respiratory/Pulmonary Indexes
5. Rice wins innovation award for international program
6. For creating new field of science, Texas chemist wins international prize
7. QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cancer and HealthShares(TM) Neuroscience Indexes
8. Tasker Products to Showcase Tasker Blue at International Poultry Expo
9. Society for Biological Engineering Holds First International Conference on Stem Cell Engineering
10. CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium
11. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... ... issued by the Office of the National Coordinator for Health IT (ONC) outlining ... if clinically relevant data were available when and where it was needed. The ...
(Date:5/25/2016)... ... 25, 2016 , ... Biohaven Pharmaceutical Holding Company Ltd. (Biohaven) ... company’s orphan drug designation request covering BHV-4157 for the treatment of Spinocerebellar Ataxia ... , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder that is estimated ...
(Date:5/24/2016)... ... 24, 2016 , ... Media Cybernetics, global image analysis leader, ... branding reflects a results-driven revitalization for a company with a renewed focus on ... a crisp, refreshed logo and a new web presence. , “I believe that ...
(Date:5/23/2016)... -- Oxitec CEO Hadyn Parry will ... ET before the United States House Committee on Science, Space ... in controlling the spread of the Aedes aegypti ...      (Logo: http://photos.prnewswire.com/prnh/20150630/227348 ) Oxitec has ... Trials in Brazil , Panama ...
Breaking Biology Technology:
(Date:3/22/2016)... PUNE, India , March 22, 2016 ... new market research report "Electronic Sensors Market for ... Fingerprint, Proximity, & Others), Application (Communication & ... and Geography - Global Forecast to 2022", ... consumer industry is expected to reach USD ...
(Date:3/18/2016)... LONDON , March 18, 2016 ... Established Suppliers of Biometrics, ICT, Manned & Unmanned Vehicles, Physical ... & security companies in the border security market and ... and Europe has led ... your companies improved success. --> defence & ...
(Date:3/15/2016)... -- Yissum Research Development Company of the Hebrew ... Hebrew University, announced today the formation of Neteera ... human biological indicators. Neteera Technologies has completed its first ... ... emissions from sweat ducts, enables reliable and speedy biometric ...
Breaking Biology News(10 mins):